Objective: The policy of primary repair of complete atrioventricular septal
defect (CAVSD), using a two-patch technique, was evaluated with special at
tention to the risk of implantation of a prosthetic atrioventricular (AV) v
alve. Methods: From 1986 to 1999, all 97 patients who underwent primary rep
air for CAVSD were included in a retrospective analysis. Seventy-five patie
nts (75%) had Down's syndrome. Preoperative echocardiographic AV valve regu
rgitation was absent or limited in 85 (88%), moderate in seven (7%) and sev
ere in five (5%). Fifty-six patients (58%) were on diuretics, six (6%) on a
rtificial ventilation and four (4%) were on inotropic support. The mean age
at operation was 10.2 months (SD, 16.4). with a mean weight of 5.9 kg (SD,
3.7). Results: Early mortality comprised three patients (4%), and late mor
tality two patients. Follow up was complete and comprised 402 patient-years
(mean, 4.5 years; SD, 3.2). The cumulative survival at 10 years was 93% (9
5% CI, 89-97%). Multivariate analysis with regard to mortality revealed no
associations with any of the analyzed factors. Fight patients were reoperat
ed, all for regurgitant left AV valve. The reoperation-free survival at 10
years was 83% (95% CI, 75-91%). Multivariate analysis with regard to reoper
ation showed bring on preoperative diuretics to be a decreasing risk factor
(Odd's Ratio (OR), 0.13; 95% CI, 0.00-0.99; P = 0.005) and significant pos
toperative left AV valve regurgitation to be an increasing risk factor (OR,
9.90; 95% CI. 1.90-53.0; P = 0.001). Only one prosthetic valve was implant
ed (annual linearized risk of 0.002/patient-year). At the latest follow up
of the surviving patients, left AV valve regurgitation was absent or limite
d in 83 (90%) and moderate in nine (10%). Right AV valve regurgitation was
absent or limited in all 92 (100%) patients. All surviving patients are thr
iving well, seven (8%) of whom are on diuretics. Conclusions: Primary repai
r of CAVSD with a two-patch technique, including cleft closure of the left
AV valve, has good clinical and functional results without problems for the
right-sided AV valve. The need for prosthetic valve implantation for the l
eft AV valve is minimal. (C) 2000 Elsevier Science B.V. All rights reserved
.